Eunice Wang, MD, and Bijal Shah, MD, MS, discussed unmet needs for adult patients with relapsed/refractory ALL and reflect on the current treatment landscape.
This content originally appeared on our sister site, OncLive.
BASECAMP-1 Trial Identifies Patients With Solid Tumors to Assess Novel CAR T-Cell Therapy
September 22nd 2023J. Randolph Hecht, MD, discusses the challenges researchers have faced in the development of cellular therapy for patients with solid tumors, and details how A2B530 could potentially overcome some of these obstacles.
2 Clarke Drive
Cranbury, NJ 08512